300529 健帆生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)13.40325.30912.98725.66138.822
总资产报酬率 ROA (%)8.30115.0137.96517.39729.821
投入资产回报率 ROIC (%)9.32416.9088.87119.29733.561

边际利润分析
销售毛利率 (%)79.59180.77979.74182.33584.972
营业利润率 (%)37.68539.04528.28941.32052.998
息税前利润/营业总收入 (%)37.45438.82325.34040.09752.132
净利润/营业总收入 (%)29.03930.41022.14635.35944.697

收益指标分析
经营活动净收益/利润总额(%)97.04095.92396.29392.58395.405
价值变动净收益/利润总额(%)7.1864.2810.0001.0342.041
营业外收支净额/利润总额(%)-6.218-3.814-4.376-1.244-0.761

偿债能力分析
流动比率 (X)4.2553.6303.9934.5927.911
速动比率 (X)3.8013.1903.5294.1057.402
资产负债率 (%)38.06738.05743.12333.71329.655
带息债务/全部投入资本 (%)25.44626.70932.35523.88318.524
股东权益/带息债务 (%)272.896260.957197.769304.068421.911
股东权益/负债合计 (%)162.722162.726131.670195.735235.469
利息保障倍数 (X)18.96032.037-14.371-56.060-112.140

营运能力分析
应收账款周转天数 (天)6.6658.62627.77035.46029.367
存货周转天数 (天)276.064252.816339.301223.177142.015